Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

The Word Brain 2015Free PDF | Print | Web
A short guide to fast language learning

Free Abstracts

  Malignant Melanoma

  Free Subscription


Articles published in Cancer

Retrieve available abstracts of 34 articles:
HTML format
Text format



Single Articles


    August 2016
  1. BHATIA S, Margolin K
    Disparate clinical activity of PD-1 blockade in melanoma subtypes: Know thy enemy!
    Cancer. 2016 Aug 17. doi: 10.1002/cncr.30260.
    PubMed     Text format    


  2. SHOUSHTARI AN, Munhoz RR, Kuk D, Ott PA, et al
    The efficacy of anti-PD-1 agents in acral and mucosal melanoma.
    Cancer. 2016 Aug 17. doi: 10.1002/cncr.30259.
    PubMed     Text format     Abstract available


  3. ALGAZI AP, Tsai KK, Shoushtari AN, Munhoz RR, et al
    Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-1L antibodies.
    Cancer. 2016 Aug 17. doi: 10.1002/cncr.30258.
    PubMed     Text format     Abstract available


  4. JHAWAR SR, Kaufman HL, Goyal S
    Timing and type of immune checkpoint therapy affect the early radiographic response of melanoma brain metastases to stereotactic radiosurgery.
    Cancer. 2016 Aug 6. doi: 10.1002/cncr.30244.
    PubMed     Text format    


  5. YU JB, Chiang VL
    Reply to timing and type of immune checkpoint therapy affect the early radiographic response of melanoma brain metastases to stereotactic radiosurgery.
    Cancer. 2016 Aug 6. doi: 10.1002/cncr.30243.
    PubMed     Text format    


    July 2016
  6. CURIEL-LEWANDROWSKI C, Swetter SM
    Lack of harms from community-based melanoma screening by primary care providers.
    Cancer. 2016 Jul 8. doi: 10.1002/cncr.30194.
    PubMed     Text format    


  7. WEINSTOCK MA, Ferris LK, Saul MI, Geller AC, et al
    Downstream consequences of melanoma screening in a community practice setting: First results.
    Cancer. 2016 Jul 8. doi: 10.1002/cncr.30177.
    PubMed     Text format     Abstract available


    June 2016
  8. QIAN JM, Yu JB, Kluger HM, Chiang VL, et al
    Timing and type of immune checkpoint therapy affect the early radiographic response of melanoma brain metastases to stereotactic radiosurgery.
    Cancer. 2016 Jun 10. doi: 10.1002/cncr.30138.
    PubMed     Text format     Abstract available


    April 2016
  9. PRINTZ C
    FDA approves new treatment of metastatic melanoma.
    Cancer. 2016;122:1149.
    PubMed     Text format    


    March 2016
  10. CHATTOPADHYAY C, Kim DW, Gombos DS, Oba J, et al
    Uveal melanoma: From diagnosis to treatment and the science in between.
    Cancer. 2016 Mar 15. doi: 10.1002/cncr.29727.
    PubMed     Text format     Abstract available


    February 2016
  11. TRICOLI JV, Blair DG, Anders CK, Bleyer A, et al
    Biologic and clinical characteristics of adolescent and young adult cancers: Acute lymphoblastic leukemia, colorectal cancer, breast cancer, melanoma, and sarcoma.
    Cancer. 2016 Feb 5. doi: 10.1002/cncr.29871.
    PubMed     Text format     Abstract available


    October 2015
  12. STANG A, Jockel KH
    Does skin cancer screening save lives? A detailed analysis of mortality time trends in Schleswig-Holstein and Germany.
    Cancer. 2015 Oct 19. doi: 10.1002/cncr.29755.
    PubMed     Text format     Abstract available


    August 2015
  13. WEISS SA, Hanniford D, Hernando E, Osman I, et al
    Revisiting determinants of prognosis in cutaneous melanoma.
    Cancer. 2015 Aug 26. doi: 10.1002/cncr.29634.
    PubMed     Text format     Abstract available


  14. BUCHBINDER EI, Sosman JA, Lawrence DP, McDermott DF, et al
    Phase 2 study of sunitinib in patients with metastatic mucosal or acral melanoma.
    Cancer. 2015 Aug 11. doi: 10.1002/cncr.29622.
    PubMed     Text format     Abstract available


    July 2015
  15. MENZIES AM, Wilmott JS, Drummond M, Lo S, et al
    Clinicopathologic features associated with efficacy and long-term survival in metastatic melanoma patients treated with BRAF or combined BRAF and MEK inhibitors.
    Cancer. 2015 Jul 28. doi: 10.1002/cncr.29586.
    PubMed     Text format     Abstract available


    June 2015
  16. PRINTZ C
    Coffee may lower risk of malignant melanoma.
    Cancer. 2015;121:1913.
    PubMed     Text format    


  17. LEHRER S
    Finasteride and dutasteride may reduce melanoma risk.
    Cancer. 2015 Jun 8. doi: 10.1002/cncr.29520.
    PubMed     Text format    


  18. LI WQ, Han J
    Reply to finasteride and dutasteride may reduce melanoma risk.
    Cancer. 2015 Jun 8. doi: 10.1002/cncr.29519.
    PubMed     Text format    


    May 2015
  19. ZHANG M, Qureshi AA, Fortner RT, Hankinson SE, et al
    Teenage acne and cancer risk in US women: A prospective cohort study.
    Cancer. 2015;121:1681-7.
    PubMed     Text format     Abstract available


    April 2015
  20. PRINTZ C
    Sun behaviors and genes may affect future melanoma risk.
    Cancer. 2015;121:1157.
    PubMed     Text format    


    March 2015
  21. BARTLETT EK, Simmons KD, Wachtel H, Roses RE, et al
    The rise in metastasectomy across cancer types over the past decade.
    Cancer. 2015;121:747-57.
    PubMed     Text format     Abstract available


    February 2015
  22. YAMAMOTO M, Fisher KJ, Wong JY, Koscso JM, et al
    Sentinel lymph node biopsy is indicated for patients with thick clinically lymph node-negative melanoma.
    Cancer. 2015 Feb 11. doi: 10.1002/cncr.29239.
    PubMed     Text format     Abstract available


    December 2014
  23. KOSARY CL, Altekruse SF, Ruhl J, Lee R, et al
    Clinical and prognostic factors for melanoma of the skin using SEER registries: Collaborative stage data collection system, version 1 and version 2.
    Cancer. 2014;120 Suppl S23:3807-3814.
    PubMed     Text format     Abstract available


  24. HUMPHRIS JL, Johns AL, Simpson SH, Cowley MJ, et al
    Clinical and pathologic features of familial pancreatic cancer.
    Cancer. 2014;120:3669-75.
    PubMed     Text format     Abstract available


    September 2014
  25. LEE SM, Moon J, Redman BG, Chidiac T, et al
    Phase 2 study of RO4929097, a gamma-secretase inhibitor, in metastatic melanoma: SWOG 0933.
    Cancer. 2014 Sep 23. doi: 10.1002/cncr.29055.
    PubMed     Text format     Abstract available


    August 2014
  26. FLEMING NH, Zhong J, da Silva IP, Vega-Saenz de Miera E, et al
    Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients.
    Cancer. 2014 Aug 25. doi: 10.1002/cncr.28981.
    PubMed     Text format     Abstract available


  27. PRINTZ C
    Young people with non-melanoma skin cancers are at higher risk of other cancers.
    Cancer. 2014;120:2382-3.
    PubMed     Text format    


    July 2014
  28. LAUNAY-VACHER V, Zimner-Rapuch S, Poulalhon N, Fraisse T, et al
    Acute renal failure associated with the new BRAF inhibitor vemurafenib: a case series of 8 patients.
    Cancer. 2014;120:2158-63.
    PubMed     Text format     Abstract available


  29. CHAN MM, Haydu LE, Menzies AM, Azer MW, et al
    The nature and management of metastatic melanoma after progression on BRAF inhibitors: Effects of extended BRAF inhibition.
    Cancer. 2014 Jul 1. doi: 10.1002/cncr.28851.
    PubMed     Text format     Abstract available


    May 2014
  30. TISHLER RB
    Increased clarity on the use of radiotherapy in the management of desmoplastic melanoma.
    Cancer. 2014;120:1315-8.
    PubMed     Text format    


    March 2014
  31. HAMID O, Ilaria R Jr, Garbe C, Wolter P, et al
    A randomized, open-label clinical trial of tasisulam sodium versus paclitaxel as second-line treatment in patients with metastatic melanoma.
    Cancer. 2014 Mar 26. doi: 10.1002/cncr.28635.
    PubMed     Text format     Abstract available


    February 2014
  32. ASCIERTO PA, Margolin K
    Ipilimumab before BRAF inhibitor treatment may be more beneficial than vice versa for the majority of patients with advanced melanoma.
    Cancer. 2014 Feb 27. doi: 10.1002/cncr.28622.
    PubMed     Text format    


  33. ACKERMAN A, Klein O, McDermott DF, Wang W, et al
    Outcomes of patients with metastatic melanoma treated with immunotherapy prior to or after BRAF inhibitors.
    Cancer. 2014 Feb 27. doi: 10.1002/cncr.28620.
    PubMed     Text format     Abstract available


  34. AZER MW, Menzies AM, Haydu LE, Kefford RF, et al
    Patterns of response and progression in patients with BRAF-mutant melanoma metastatic to the brain who were treated with dabrafenib.
    Cancer. 2014;120:530-6.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Pfizer Oncology.

Design: